Table 2.
Lipid metabolites distinguish IBD patients who developed leukopenia from those who do not.
| Lipid species | Formula | RT [min] | Frequency | P | FDR | FC |
|---|---|---|---|---|---|---|
| LacCer (d18:1/16:0) | C46H88O13N1 | 11.42858 | 50 | 7.98E-05 | 0.0083 | 1.53 |
| TG (15:0/16:0/16:1) | C50H98O6N1 | 17.49223 | 45 | 0.0051 | 0.038 | 1.22 |
| TG (16:0/18:2/24:7) | C61H101O6 | 17.47783 | 43 | 0.0026 | 0.030 | 1.19 |
| TG (18:1/20:4/22:4) | C63H105O6 | 17.81924 | 49 | 0.0036 | 0.033 | 1.20 |
| TG (18:1/20:5/22:4) | C63H103O6 | 17.50232 | 50 | 0.0039 | 0.033 | 1.24 |
| TG (22:5/18:2/18:2) | C61H104O6N1 | 16.97768 | 50 | 1.72E-04 | 0.0084 | 1.35 |